| |
| |
|
| Insider
Information: |
Rudnick Seth |
| Relationship: |
|
| City: |
Rowayton |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
170,536 |
|
|
Indirect Shares
|
36,411 |
|
|
| Direct
Value |
$17,729 |
|
|
|
Indirect Value
|
$21,086 |
|
|
| Total
Shares |
206,947 |
|
|
| Total
Value |
$38,816 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunicon Corp |
IMMCQ |
Director |
2004-04-21 |
17,269 |
|
0 |
Premium* |
|
|
Epirus Biopharmaceuticals Inc |
EPRS |
Director |
2005-11-15 |
5,486 |
2005-11-15 |
0 |
Premium* |
|
|
Northstar Neuroscience Inc |
NSTR |
Director |
2006-05-04 |
9,000 |
|
0 |
Premium* |
|
|
POZEN Inc |
POZN |
Director |
2015-06-23 |
47,501 |
2011-07-25 |
0 |
Premium* |
|
|
Square 1 Financial Inc |
SQBK |
Director |
2015-10-06 |
0 |
2014-06-16 |
1,145 |
Premium* |
|
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-11 |
86,891 |
2017-05-11 |
30,000 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
|
2021-06-29 |
4,389 |
2021-06-29 |
5,266 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-06-29 |
4 |
AS |
$22.35 |
$223,477 |
D/D |
(10,000) |
4,389 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-06-29 |
4 |
OE |
$0.30 |
$3,717 |
D/D |
10,000 |
14,389 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,389 |
4,389 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2020-12-24 |
4 |
AS |
$20.10 |
$18,572 |
I/I |
(924) |
5,266 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2020-12-23 |
4 |
AS |
$20.18 |
$264,757 |
I/I |
(13,118) |
6,190 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2020-12-22 |
4 |
AS |
$20.33 |
$385,702 |
I/I |
(18,974) |
19,308 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2020-12-10 |
4 |
AS |
$20.00 |
$10,921 |
I/I |
(546) |
38,282 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2020-12-09 |
4 |
AS |
$20.32 |
$117,284 |
I/I |
(5,773) |
38,828 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2020-12-08 |
4 |
AS |
$20.19 |
$265,694 |
I/I |
(13,161) |
44,601 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2020-12-01 |
4 |
AS |
$20.09 |
$10,449 |
I/I |
(520) |
57,762 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-12-04 |
4 |
AS |
$39.31 |
$393,146 |
D/D |
(10,000) |
0 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-12-04 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-11-05 |
4 |
AS |
$41.53 |
$415,347 |
D/D |
(10,000) |
0 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-11-05 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-10-04 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-10-04 |
4 |
AS |
$49.65 |
$497,210 |
D/D |
(10,000) |
0 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-09-04 |
4 |
AS |
$59.93 |
$599,483 |
D/D |
(10,000) |
0 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-09-04 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-08-06 |
4 |
AS |
$50.69 |
$506,901 |
D/D |
(10,000) |
0 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-08-06 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Director |
– • – |
2017-05-22 |
4 |
A |
$0.00 |
$0 |
I/I |
2,757 |
58,282 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Director |
– • – |
2017-05-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
55,525 |
|
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
86,891 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2017-03-15 |
4 |
B |
$2.26 |
$33,950 |
D/D |
15,000 |
79,391 |
2.39 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-11-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
30,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
